AGIO 93.04 Agios Pharmaceuticals Inc $AGIO Hit a 5
Post# of 102933
Posted On: 11/20/2014 10:08:23 AM
AGIO 93.04 Agios Pharmaceuticals Inc $AGIO Hit a 52 week high of 95.79 Closing the day 09:45 at 93.04 -2.93 -3.05% With a day low of 92.47 and a total volume of 180,647.
AGIO Recent Posts: http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/
AGIO Agios Pharmaceuticals Inc Recent Headline News
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 16 mins ago
Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as its shares rose roughly 15% on the day.
ICUI: 81.20 (-1.00), GWPH: 79.24 (+0.68), AGIO: 94.46 (-1.51), OSUR: 8.62 (-0.05)
Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE
L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
DL: 17.77 (+0.03), SSI: 19.11 (+0.32), EBR: 2.29 (-0.01), AGIO: 94.46 (-1.51)
Target and Lowe's are big market movers
AP - Wed Nov 19, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 14.03 (+0.11), VIPS: 22.43 (-0.01), CLV: 7.85 (-0.11), TGT: 71.19 (-1.31), AGIO: 94.46 (-1.51), CLF: 8.04 (-0.13), OPLK: 24.17 (-0.01), DISH: 73.25 (-1.41)
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO)
at The Street - Wed Nov 19, 1:11PM CST
TheStreet's Jim Cramer explains why investors in Agios Pharmaceuticals (AGIO) are winners and who could buy the $3 billion company.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)
Nasdaq stocks posting largest percentage increases
AP - Wed Nov 19, 12:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
RESN: 8.31 (-0.43), CLUB: 6.25 (+0.18), SPLS: 14.03 (+0.11), FNHC: 25.53 (-0.70), AGIO: 94.46 (-1.51), OPLK: 24.17 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 11:55AM CST
CLUB: 6.25 (+0.18), LEJU: 12.01 (-0.06), ANV: 1.66 (+0.17), SSI: 19.11 (+0.32), ROX: 1.76 (+0.08), CLF: 8.04 (-0.13), BIND: 8.25 (-0.15), NADL: 3.21 (+0.05), CSTM: 17.29 (-0.64), VRML: 1.45 (-0.05), WTT: 2.66 (+0.06), CANF: 3.59 (-0.23), DL: 17.77 (+0.03), BAMM: 1.84 (+0.19), RELV: 1.28 (+0.09), SNCR: 42.79 (+0.54), ATLC: 2.50 (-0.10), AGIO: 94.46 (-1.51), BBLU: 1.10 (-0.01), OPLK: 24.17 (-0.01)
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'
at The Street - Wed Nov 19, 10:21AM CST
TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)
Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - Wed Nov 19, 8:11AM CST
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 14.03 (+0.11), LEJU: 12.01 (-0.06), TSLA: 249.37 (+1.63), FCAU: 12.17 (-0.06), LITB: 7.27 (-0.13), TTM: 46.39 (-0.31), DL: 17.77 (+0.03), VA: 34.08 (+0.87), TGT: 71.19 (-1.31), GM: 31.99 (-0.16), AGIO: 94.46 (-1.51), LOW: 62.44 (+0.18), HMC: 31.02 (-0.11), EJ: 8.67 (+0.15), PETM: 77.72 (-0.47)
Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:01AM CST
AGIO: 94.46 (-1.51)
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
GlobeNewswire - Tue Nov 18, 5:01PM CST
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML -
AGIO: 94.46 (-1.51)
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 17.03 (-0.07), SIX: 39.64 (-0.48), AGIO: 94.46 (-1.51)
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST
XBI: 170.74 (+0.78), SLXP: 103.78 (+0.15), ICPT: 156.53 (+0.60), IBB: 293.63 (-0.58), AGIO: 94.46 (-1.51)
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST
AGIO: 94.46 (-1.51)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST
BEBE: 2.55 (+0.03), ANET: 75.92 (-1.08), TKMR: 16.00 (-0.12), ORBC: 6.24 (-0.07), MDRX: 11.97 (-0.19), RMTI: 9.05 (-0.76), CTIC: 2.18 (unch), SHLD: 35.68 (+0.48), UBNT: 29.58 (+0.02), RIG: 25.75 (+0.39), KGC: 2.83 (+0.09), APT: 2.77 (+0.02), ANF: 29.40 (+0.42), MITK: 3.69 (-0.13), ZNGA: 2.69 (unch), CNET: 1.78 (-0.04), KING: 16.14 (+0.20), NETE: 1.34 (+0.03), SLXP: 103.99 (+0.36), RPRX: 8.79 (-0.08), NADL: 3.21 (+0.05), PGNX: 6.41 (+0.04), AVNR: 13.68 (+0.11), FSLR: 48.81 (-0.01), DVA: 74.93 (-0.19), NDLS: 22.28 (+0.20), ICPT: 156.53 (+0.60), AGIO: 94.46 (-1.51), PLNR: 7.27 (+0.04)
Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST
AGIO: 94.46 (-1.51)
Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 94.46 (-1.51)
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 94.46 (-1.51)
AGIO Recent Posts: http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/
AGIO Agios Pharmaceuticals Inc Recent Headline News
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 16 mins ago
Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as its shares rose roughly 15% on the day.
ICUI: 81.20 (-1.00), GWPH: 79.24 (+0.68), AGIO: 94.46 (-1.51), OSUR: 8.62 (-0.05)
Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE
L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . DL: 17.77 (+0.03), SSI: 19.11 (+0.32), EBR: 2.29 (-0.01), AGIO: 94.46 (-1.51)
Target and Lowe's are big market movers
AP - Wed Nov 19, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 14.03 (+0.11), VIPS: 22.43 (-0.01), CLV: 7.85 (-0.11), TGT: 71.19 (-1.31), AGIO: 94.46 (-1.51), CLF: 8.04 (-0.13), OPLK: 24.17 (-0.01), DISH: 73.25 (-1.41)
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO)
at The Street - Wed Nov 19, 1:11PM CST
TheStreet's Jim Cramer explains why investors in Agios Pharmaceuticals (AGIO) are winners and who could buy the $3 billion company.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)
Nasdaq stocks posting largest percentage increases
AP - Wed Nov 19, 12:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
RESN: 8.31 (-0.43), CLUB: 6.25 (+0.18), SPLS: 14.03 (+0.11), FNHC: 25.53 (-0.70), AGIO: 94.46 (-1.51), OPLK: 24.17 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 11:55AM CST
CLUB: 6.25 (+0.18), LEJU: 12.01 (-0.06), ANV: 1.66 (+0.17), SSI: 19.11 (+0.32), ROX: 1.76 (+0.08), CLF: 8.04 (-0.13), BIND: 8.25 (-0.15), NADL: 3.21 (+0.05), CSTM: 17.29 (-0.64), VRML: 1.45 (-0.05), WTT: 2.66 (+0.06), CANF: 3.59 (-0.23), DL: 17.77 (+0.03), BAMM: 1.84 (+0.19), RELV: 1.28 (+0.09), SNCR: 42.79 (+0.54), ATLC: 2.50 (-0.10), AGIO: 94.46 (-1.51), BBLU: 1.10 (-0.01), OPLK: 24.17 (-0.01)
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'
at The Street - Wed Nov 19, 10:21AM CST
TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)
Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - Wed Nov 19, 8:11AM CST
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 14.03 (+0.11), LEJU: 12.01 (-0.06), TSLA: 249.37 (+1.63), FCAU: 12.17 (-0.06), LITB: 7.27 (-0.13), TTM: 46.39 (-0.31), DL: 17.77 (+0.03), VA: 34.08 (+0.87), TGT: 71.19 (-1.31), GM: 31.99 (-0.16), AGIO: 94.46 (-1.51), LOW: 62.44 (+0.18), HMC: 31.02 (-0.11), EJ: 8.67 (+0.15), PETM: 77.72 (-0.47)
Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:01AM CST
AGIO: 94.46 (-1.51)
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
GlobeNewswire - Tue Nov 18, 5:01PM CST
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML -
AGIO: 94.46 (-1.51)
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 17.03 (-0.07), SIX: 39.64 (-0.48), AGIO: 94.46 (-1.51)
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST
XBI: 170.74 (+0.78), SLXP: 103.78 (+0.15), ICPT: 156.53 (+0.60), IBB: 293.63 (-0.58), AGIO: 94.46 (-1.51)
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST
AGIO: 94.46 (-1.51)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST
BEBE: 2.55 (+0.03), ANET: 75.92 (-1.08), TKMR: 16.00 (-0.12), ORBC: 6.24 (-0.07), MDRX: 11.97 (-0.19), RMTI: 9.05 (-0.76), CTIC: 2.18 (unch), SHLD: 35.68 (+0.48), UBNT: 29.58 (+0.02), RIG: 25.75 (+0.39), KGC: 2.83 (+0.09), APT: 2.77 (+0.02), ANF: 29.40 (+0.42), MITK: 3.69 (-0.13), ZNGA: 2.69 (unch), CNET: 1.78 (-0.04), KING: 16.14 (+0.20), NETE: 1.34 (+0.03), SLXP: 103.99 (+0.36), RPRX: 8.79 (-0.08), NADL: 3.21 (+0.05), PGNX: 6.41 (+0.04), AVNR: 13.68 (+0.11), FSLR: 48.81 (-0.01), DVA: 74.93 (-0.19), NDLS: 22.28 (+0.20), ICPT: 156.53 (+0.60), AGIO: 94.46 (-1.51), PLNR: 7.27 (+0.04)
Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST
AGIO: 94.46 (-1.51)
Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 94.46 (-1.51)
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 94.46 (-1.51)
(0)
(0)